Shattuck Labs (STTK) Change in Account Payables (2019 - 2026)
Shattuck Labs (STTK) reported Change in Account Payables of -$911000.0 for Q1 2026, down 2.82% year-over-year from -$937451.8 in Q1 2025, and down 197.02% quarter-over-quarter from $939000.0 in Q4 2025.
Shattuck Labs (STTK) Change in Account Payables (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Change in Account Payables data on file, last reported at -$911000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$911000.0, down 2.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$343000.0 (up 64.27% YoY), and the FY2025 annual result was -$318000.0, down 138.22% from the prior year.
- Change in Account Payables slipped to -$911000.0 in Q1 2026 per STTK's latest filing, from $939000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.4 million in Q4 2022 and troughed at -$7.7 million in Q1 2022.
- A 5-year average of -$521647.1 and a median of -$475000.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables slumped 723.53% in 2022, then surged 497.39% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $4.4 million in 2022, then tumbled by 110.91% to -$475000.0 in 2023, then fell by 6.95% to -$508000.0 in 2024, then jumped by 284.84% to $939000.0 in 2025, then tumbled by 197.02% to -$911000.0 in 2026.
- Business Quant data shows STTK's Change in Account Payables at -$911000.0 in Q1 2026, $939000.0 in Q4 2025, and $687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | -911,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -911,000.00 |
| Mar 31, 2026 | -911,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -886,000.00 |
| Mar 31, 2025 | -886,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Dec 31, 2023 | -475,000.00 |
| Dec 31, 2023 | -475,000.00 |